Does TACROLIMUS Cause Leukocytosis? 200 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 200 reports of Leukocytosis have been filed in association with TACROLIMUS (Tacrolimus). This represents 0.2% of all adverse event reports for TACROLIMUS.
200
Reports of Leukocytosis with TACROLIMUS
0.2%
of all TACROLIMUS reports
43
Deaths
166
Hospitalizations
How Dangerous Is Leukocytosis From TACROLIMUS?
Of the 200 reports, 43 (21.5%) resulted in death, 166 (83.0%) required hospitalization, and 50 (25.0%) were considered life-threatening.
Is Leukocytosis Listed in the Official Label?
Yes, Leukocytosis is listed as a known adverse reaction in the official FDA drug label for TACROLIMUS.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Leukocytosis?
CLOZAPINE (1,460)
PREDNISONE (419)
ACETAMINOPHEN (356)
METFORMIN (345)
RUXOLITINIB (320)
RITUXIMAB (272)
METHYLPREDNISOLONE (252)
AMLODIPINE (250)
IBRUTINIB (243)
DEXAMETHASONE (235)
Which TACROLIMUS Alternatives Have Lower Leukocytosis Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB